An Assessment of Dispersion-Corrected DFT Methods for Modeling Nonbonded Interactions in Protein Kinase Inhibitor
Yan Zhu1, Saad Alqahtani1,2, Xiche Hu1
1Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA.
Molecules (Basel, Switzerland)
|January 23, 2024
Summary
Accurate modeling of protein kinase inhibitors requires benchmarking density functional theory (DFT) methods. B3LYP/def2-TZVP and RIJK RI-B2PLYP/def2-QZVP offer the best balance of accuracy and efficiency for nonbonded interactions.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Accurate modeling of nonbonded interactions between protein kinases and inhibitors is crucial for structure-based drug design.
- Density functional theory (DFT) methods are promising for quantifying these protein-ligand interactions, but accuracy varies with functionals and basis sets.
Purpose of the Study:
- To benchmark nine widely used DFT methods for modeling nonbonded interactions in protein kinase inhibitors.
- To identify an optimal DFT approach balancing accuracy and computational efficiency.
Main Methods:
- Benchmarking of nine DFT functionals (BLYP, TPSS, B97, ωB97X, B3LYP, M062X, PW6B95, B2PLYP, PWPB95) with D3BJ dispersion correction and def2-SVP, def2-TZVP, def2-QZVP basis sets.
- Calculation of nonbonded interaction energies for 49 motifs from 2139 kinase-inhibitor structures at the CCSD(T)/CBS level of theory as reference.
- Application of RI, RIJK, and RIJCOSX approximations for selected functionals.
Main Results:
- B3LYP/def2-TZVP and RIJK RI-B2PLYP/def2-QZVP methods demonstrated the best performance.
- These methods provide an optimal combination of accuracy and computational efficiency for modeling nonbonded interactions.
Conclusions:
- B3LYP/def2-TZVP and RIJK RI-B2PLYP/def2-QZVP are well-suited for efficient modeling of nonbonded interactions in protein kinase inhibitor recognition.
- This study provides guidance for selecting appropriate DFT methods in structure-based drug design.
Related Concept Videos
Protein-Drug Binding: Determination Methods
189
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
189
Physiological Pharmacokinetic Models: Assumption with Protein Binding
45
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
45
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Protein-Drug Binding: Mechanism and Kinetics
488
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
488


